Tweet
Connor Clark & Lunn Investment Management Ltd. lifted its stake in SeaSpine Holdings Corp (NASDAQ:SPNE) by 8.8% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 94,980 shares of the medical equipment provider's stock after acquiring an additional 7,675 shares during the period. Connor Clark & Lunn Investment Management Ltd.'s holdings in SeaSpine were worth $1,199,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of SPNE. Northern Trust Corp raised its stake in shares of SeaSpine by 35.3% in the 1st quarter. Northern Trust Corp now owns 35,512 shares of the medical equipment provider's stock valued at $360,000 after acquiring an additional 9,271 shares in the last quarter. Wedge Capital Management L L P NC bought a new position in SeaSpine in the 2nd quarter worth approximately $734,000. FNY Investment Advisers LLC bought a new position in SeaSpine in the 2nd quarter worth approximately $892,000. Acadian Asset Management LLC increased its position in SeaSpine by 68.9% in the 2nd quarter. Acadian Asset Management LLC now owns 72,991 shares of the medical equipment provider's stock worth $921,000 after buying an additional 29,782 shares during the period. Finally, The Manufacturers Life Insurance Company increased its position in SeaSpine by 29.8% in the 1st quarter. The Manufacturers Life Insurance Company now owns 382,698 shares of the medical equipment provider's stock worth $3,881,000 after buying an additional 87,891 shares during the period. 46.28% of the stock is currently owned by institutional investors and hedge funds. Get SeaSpine alerts:
Several brokerages have commented on SPNE. Zacks Investment Research downgraded SeaSpine from a "hold" rating to a "sell" rating in a research report on Friday, August 3rd. HC Wainwright reaffirmed a "buy" rating on shares of SeaSpine in a research report on Monday, July 16th. Cantor Fitzgerald reaffirmed a "buy" rating and issued a $16.00 price target on shares of SeaSpine in a research report on Monday, July 30th. Finally, ValuEngine raised SeaSpine from a "hold" rating to a "buy" rating in a research report on Saturday, June 2nd. One analyst has rated the stock with a sell rating and six have given a buy rating to the stock. The company currently has an average rating of "Buy" and a consensus target price of $17.17. Shares of NASDAQ SPNE opened at $13.99 on Friday. The company has a current ratio of 3.20, a quick ratio of 1.48 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $204.93 million, a price-to-earnings ratio of -5.42 and a beta of 0.40. SeaSpine Holdings Corp has a 12 month low of $8.76 and a 12 month high of $14.31.
SeaSpine (NASDAQ:SPNE) last issued its quarterly earnings results on Monday, July 30th. The medical equipment provider reported ($0.50) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.48) by ($0.02). The business had revenue of $36.41 million during the quarter, compared to the consensus estimate of $34.12 million. SeaSpine had a negative return on equity of 27.65% and a negative net margin of 21.75%. research analysts forecast that SeaSpine Holdings Corp will post -1.95 earnings per share for the current fiscal year.
In other SeaSpine news, Director Stuart Essig sold 43,496 shares of SeaSpine stock in a transaction that occurred on Thursday, August 2nd. The stock was sold at an average price of $14.00, for a total value of $608,944.00. The sale was disclosed in a filing with the SEC, which is available through this link . Insiders own 13.54% of the company's stock.
SeaSpine Company Profile
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical regions of the spine.
Further Reading: Google Finance Portfolio Tips and Tricks
Want to see what other hedge funds are holding SPNE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SeaSpine Holdings Corp (NASDAQ:SPNE). Receive News & Ratings for SeaSpine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaSpine and related companies with MarketBeat.com's FREE daily email newsletter 